Immix Biopharma Statistics Share Statistics Immix Biopharma has 28.81M
shares outstanding. The number of shares has increased by 1.55%
in one year.
Shares Outstanding 28.81M Shares Change (YoY) 1.55% Shares Change (QoQ) 0.56% Owned by Institutions (%) 9.83% Shares Floating 19.38M Failed to Deliver (FTD) Shares 4,333 FTD / Avg. Volume 2.03%
Short Selling Information The latest short interest is 369.04K, so 1.28% of the outstanding
shares have been sold short.
Short Interest 369.04K Short % of Shares Out 1.28% Short % of Float 2.12% Short Ratio (days to cover) 1.53
Valuation Ratios The PE ratio is -2.88 and the forward
PE ratio is -2.7.
Immix Biopharma's PEG ratio is
0.2.
PE Ratio -2.88 Forward PE -2.7 PS Ratio 0 Forward PS 4.9 PB Ratio 4.7 P/FCF Ratio -3.95 PEG Ratio 0.2
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Immix Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.33,
with a Debt / Equity ratio of 0.08.
Current Ratio 2.33 Quick Ratio 2.33 Debt / Equity 0.08 Debt / EBITDA -0.05 Debt / FCF -0.07 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.2M Employee Count 18 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 41.04K Effective Tax Rate -0.19%
Stock Price Statistics The stock price has increased by 24.24% in the
last 52 weeks. The beta is 0.25, so Immix Biopharma's
price volatility has been higher than the market average.
Beta 0.25 52-Week Price Change 24.24% 50-Day Moving Average 2.38 200-Day Moving Average 2.12 Relative Strength Index (RSI) 43.47 Average Volume (20 Days) 213,866
Income Statement
Revenue n/a Gross Profit -115.39K Operating Income -22.67M Net Income -21.61M EBITDA -21.54M EBIT -21.66M Earnings Per Share (EPS) -0.76
Full Income Statement Balance Sheet The company has 17.68M in cash and 1.07M in
debt, giving a net cash position of 16.61M.
Cash & Cash Equivalents 17.68M Total Debt 1.07M Net Cash 16.61M Retained Earnings -75.02M Total Assets 15.64M Working Capital 2.32M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.6M
and capital expenditures -1.18M, giving a free cash flow of -15.77M.
Operating Cash Flow -14.6M Capital Expenditures -1.18M Free Cash Flow -15.77M FCF Per Share -0.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
